FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982078370> ?p ?o ?g. }

• W2982078370 abstract "Antitumor immunity has emerged as a favorable byproduct of radiation therapy (RT), whereby tumor-associated antigens released from irradiated cells unleash innate and adaptive attacks on tumors located both within and outside the radiation field. RT-induced immune responses further provide actionable targets for overcoming tumor resistance to RT (R-RT); immunotherapy (IT) with checkpoint inhibitors or Toll-like receptor (TLR) agonists can markedly improve, if not synergize with, RT in preclinical models, and several of these drugs are currently investigated as radiosensitizers in patients. In an unbiased chemical-genetic screen in a zebrafish model of tumor R-RT, we unexpectedly found that Interleukin 1 Receptor-Associated Kinase 1 (IRAK1), a core effector of TLR-mediated innate immunity, also functions in live fish and human cancer models to counter RT-induced cell death mediated by the PIDDosome complex (PIDD-RAIDD-caspase-2). IRAK1 acting both as a driver of intrinsic tumor R-RT and as an effector of RT-induced antitumor immunity would, at first glance, pose obvious therapeutic conundrums. IRAK1 inhibitors would be expected to sensitize the irradiated tumor to RT but simultaneously thwart RT-induced antitumor immunity as initiated by stromal dendritic cells. Conversely, TLR agonist-based immunotherapy would be expected to intensify RT-induced antitumor immunity but at the expense of fueling IRAK1-mediated cell survival in the irradiated tumor. We discuss how IRAK1's differential reliance on catalytic activity in the radiation vs. TLR responses might help overcome these hurdles, as well as the crucial importance of developing IRAK1 inhibitors that lack activity against IRAK4, the kinase activity of which is essential for IRAK1 activation in both pathways." @default.
• W2982078370 created "2019-11-01" @default.
• W2982078370 creator A5052029990 @default.
• W2982078370 creator A5087420789 @default.
• W2982078370 date "2019-11-13" @default.
• W2982078370 modified "2023-10-12" @default.
• W2982078370 title "Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?" @default.
• W2982078370 cites W1549853453 @default.
• W2982078370 cites W1584501990 @default.
• W2982078370 cites W1706972008 @default.
• W2982078370 cites W1925157258 @default.
• W2982078370 cites W1965805984 @default.
• W2982078370 cites W1970195004 @default.
• W2982078370 cites W1978443175 @default.
• W2982078370 cites W1987680504 @default.
• W2982078370 cites W1988217385 @default.
• W2982078370 cites W1993211211 @default.
• W2982078370 cites W1995586746 @default.
• W2982078370 cites W2012333728 @default.
• W2982078370 cites W2013995112 @default.
• W2982078370 cites W2015095309 @default.
• W2982078370 cites W2015263036 @default.
• W2982078370 cites W2030914021 @default.
• W2982078370 cites W2033023829 @default.
• W2982078370 cites W2033735518 @default.
• W2982078370 cites W2044688155 @default.
• W2982078370 cites W2057461325 @default.
• W2982078370 cites W2064434771 @default.
• W2982078370 cites W2066205838 @default.
• W2982078370 cites W2071103462 @default.
• W2982078370 cites W2071889908 @default.
• W2982078370 cites W2081447458 @default.
• W2982078370 cites W2093424661 @default.
• W2982078370 cites W2106232004 @default.
• W2982078370 cites W2118224132 @default.
• W2982078370 cites W2120009840 @default.
• W2982078370 cites W2128599664 @default.
• W2982078370 cites W2132292472 @default.
• W2982078370 cites W2134847649 @default.
• W2982078370 cites W2139064671 @default.
• W2982078370 cites W2140883212 @default.
• W2982078370 cites W2143360501 @default.
• W2982078370 cites W2144770839 @default.
• W2982078370 cites W2154681615 @default.
• W2982078370 cites W2158738222 @default.
• W2982078370 cites W2160144435 @default.
• W2982078370 cites W2168567529 @default.
• W2982078370 cites W2168970487 @default.
• W2982078370 cites W2171477441 @default.
• W2982078370 cites W2171685495 @default.
• W2982078370 cites W2260138955 @default.
• W2982078370 cites W2294733844 @default.
• W2982078370 cites W2514287253 @default.
• W2982078370 cites W2612580348 @default.
• W2982078370 cites W2616790685 @default.
• W2982078370 cites W2758252083 @default.
• W2982078370 cites W2775690235 @default.
• W2982078370 cites W2784697675 @default.
• W2982078370 cites W2890729459 @default.
• W2982078370 cites W2891420275 @default.
• W2982078370 cites W2896033748 @default.
• W2982078370 cites W2902184592 @default.
• W2982078370 cites W2908973547 @default.
• W2982078370 cites W2909508164 @default.
• W2982078370 cites W3028161231 @default.
• W2982078370 cites W4248537801 @default.
• W2982078370 cites W4297590147 @default.
• W2982078370 doi "https://doi.org/10.3389/fonc.2019.01174" @default.
• W2982078370 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6866135" @default.
• W2982078370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31799178" @default.
• W2982078370 hasPublicationYear "2019" @default.
• W2982078370 type Work @default.
• W2982078370 sameAs 2982078370 @default.
• W2982078370 citedByCount "8" @default.
• W2982078370 countsByYear W29820783702021 @default.
• W2982078370 countsByYear W29820783702022 @default.
• W2982078370 countsByYear W29820783702023 @default.
• W2982078370 crossrefType "journal-article" @default.
• W2982078370 hasAuthorship W2982078370A5052029990 @default.
• W2982078370 hasAuthorship W2982078370A5087420789 @default.
• W2982078370 hasBestOaLocation W29820783701 @default.
• W2982078370 hasConcept C126322002 @default.
• W2982078370 hasConcept C136449434 @default.
• W2982078370 hasConcept C203014093 @default.
• W2982078370 hasConcept C2777701055 @default.
• W2982078370 hasConcept C2779341262 @default.
• W2982078370 hasConcept C502942594 @default.
• W2982078370 hasConcept C509974204 @default.
• W2982078370 hasConcept C58962609 @default.
• W2982078370 hasConcept C71924100 @default.
• W2982078370 hasConcept C86803240 @default.
• W2982078370 hasConcept C8891405 @default.
• W2982078370 hasConceptScore W2982078370C126322002 @default.
• W2982078370 hasConceptScore W2982078370C136449434 @default.
• W2982078370 hasConceptScore W2982078370C203014093 @default.
• W2982078370 hasConceptScore W2982078370C2777701055 @default.
• W2982078370 hasConceptScore W2982078370C2779341262 @default.
• W2982078370 hasConceptScore W2982078370C502942594 @default.
• W2982078370 hasConceptScore W2982078370C509974204 @default.
• W2982078370 hasConceptScore W2982078370C58962609 @default.

• next